Company Filing History:
1 out of 2 
1 out of 2 Years Active: 2015
Title: Celebrating the Innovations of Inventor María Moreno Igoa
Introduction
María Moreno Igoa is an esteemed inventor based in Saragossa, Spain, recognized for his significant contributions to medical science. He holds a patent addressing the therapeutic use of the encoding sequence of the carboxy-terminal domain of the heavy chain of the tetanus toxin. This innovative work presents potential treatment avenues for severe neurological conditions, including amyotrophic lateral sclerosis (ALS).
Latest Patents
María Moreno Igoa's sole patent focuses on the "Therapeutic use of the encoding sequence of the carboxy-terminal domain of the heavy chain of the tetanus toxin." This invention showcases the potential benefits of utilizing elements from the tetanus toxin for therapeutic applications in addressing ALS, a progressive neurodegenerative disease that affects the motor neurons.
Career Highlights
Throughout his career, María Moreno Igoa has made a mark in academia, working at notable research institutions such as the University of Zaragoza and the Autonomous University of Barcelona. His educational background and research endeavors have provided him with a solid foundation to explore innovative solutions in the medical field.
Collaborations
In his efforts to advance medical research, María has collaborated with distinguished colleagues, including Ana Cristina Calvo Royo and María Jesús Muñoz Gonzalvo. Their combined expertise has contributed to the development of groundbreaking solutions in the treatment of neurological disorders.
Conclusion
María Moreno Igoa's innovative spirit and dedication to advancing medical science through his patent highlight the importance of research and collaboration in tackling complex health issues. His work exemplifies how inventions can pave the way for new therapeutic approaches, potentially transforming the lives of individuals affected by conditions like ALS.